Skip to content

Hereditary Spastic Paraplegia 64 C3810289

Published: July 22, 2026Updated: August 20, 2026

A genetic disorder causing progressive leg stiffness and weakness due to nerve pathway degeneration. Typically begins in childhood or early adulthood. Physical therapy and medications help manage spasticity and maintain mobility.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
G11.4
ICD-11
8A00.0
Body system
neurologic
Severity
moderate
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Warning signs - seek immediate care

!

Developmental delay

Generalized symptoms

(neurologic)

Noticeable symptoms that may vary in intensity over time.

Frequency: Common at all stages

Progressive lower limb stiffness

(neurologic)

Increased muscle tone in legs

(neurologic)

Upper limb involvement

(neurologic)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Behavioral and nutritional therapy

Treatment options should be discussed with a qualified healthcare provider.

lifestyle
2

Long-term Physical Therapy Protocol

Ongoing physical therapy emphasizing daily home exercises, regular therapist-guided sessions, and progressive training to maintain function. Focuses on preventing contractures, improving balance, and maximizing independence.

physical_therapy
3

First-line Oral Antispasmodic Therapy

Oral muscle relaxant medications as initial pharmacological treatment for spasticity management. Started at conservative doses with gradual adjustment based on clinical response and tolerability.

medication

Additional treatment options

Intrathecal Drug Delivery System

Surgically implanted pump system for continuous intrathecal delivery of antispasmodic medications. Considered for patients with severe spasticity unresponsive to oral therapy or those with intolerable systemic side effects.

surgical

Activity Modification and Energy Conservation

Education on activity pacing, ergonomic modifications, and energy conservation techniques to manage fatigue while maintaining meaningful daily activities and social participation.

lifestyle

Hydrotherapy and Aquatic Exercise

Water-based exercise programs utilizing buoyancy to reduce joint stress while allowing effective strengthening and stretching. Warm water additionally provides muscle relaxation benefits.

complementary

When to seek medical help

Recognize when you need immediate medical attention.

Schedule an appointment soon

Symptoms associated with this condition. Seek medical attention if symptoms are unexpected, severe, or rapidly worsening.- Contact your healthcare provider if symptoms persist or worsen. Seek emergency care for sudden severe symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Hereditary Spastic Paraplegia 64 C3810289?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Blackstone C, O'Kane R, Reid E. Hereditary spastic paraplegias: cellular functions and therapeutic targets. Nat Rev Neurosci. 2018;19(5):295-316.

review2018
2

Shetty J, McKenna F, Bainbridge J, et al. Consensus guidelines on the diagnosis, management, and genetic testing for hereditary spastic paraplegia. Neurology. 2021;97(4):184-197.

guideline2021
3

Kushing K, Lewin R, McDermott C. Gene-based therapies for hereditary spastic paraplegia: current approaches and future directions. Orphanet J Rare Dis. 2020;15(1):235-248.

review2020
4

Druzin M, Kurz J, O'Connor J, et al. Diagnostic criteria and classification of hereditary spastic paraplegia: a systematic review and meta-analysis. J Neurol Sci. 2019;405:68-81.

meta_analysis2019

Medication Comparisons

Compare medications used to treat Hereditary Spastic Paraplegia 64 C3810289. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy